Showing results (201-210 of 285) with videos related to

Sort By:
Pageof 29
Journal of Cellular Biochemistry|January 13, 2006
High glucose increases extracellular matrix production in pancreatic stellate cells by activating the renin-angiotensin systemSeung-Hyun Ko, Oak-Kee Hong, Ji-Won Kim, et al.
BMC Psychiatry|January 8, 2025
Inverse association between obesity and suicidal death riskJoonyub Lee, Seung-Hwan Lee, Mee-Kyoung Kim, et al.
Metabolism: Clinical and Experimental|June 12, 2003
The effect of rosiglitazone on serum lipoprotein(a) levels in Korean patients with type 2 diabetes mellitusSeung Hyun Ko, Ki-Ho Song, Yu-Bae Ahn, et al.
Diabetes Care|June 29, 2005
Prospective study of lipoprotein(a) as a risk factor for deteriorating renal function in type 2 diabetic patients with overt proteinuriaKi-Ho Song, Seung Hyun Ko, Hyung-Wook Kim, et al.
Lipids in Health and Disease|September 17, 2016
Triglyceride glucose index, a marker of insulin resistance, is associated with coronary artery stenosis in asymptomatic subjects with type 2 diabetesEun Young Lee, Hae Kyung Yang, Joonyub Lee, et al.
Endocrinology|June 13, 2009
Suppression of peroxisome proliferator-activated receptor gamma-coactivator-1alpha normalizes the glucolipotoxicity-induced decreased BETA2/NeuroD gene transcription and improved glucose tolerance in diabetic ratsJi-Won Kim, Young-Hye You, Dong-Sik Ham, et al.
Diabetes, Obesity & Metabolism|January 7, 2017
Efficacy and safety of adding evogliptin versus sitagliptin for metformin-treated patients with type 2 diabetes: A 24-week randomized, controlled trial with open label extensionSang-Mo Hong, Cheol-Young Park, Dong-Min Hwang, et al.
Diabetes & Metabolism Journal|February 26, 2020
Use of SGLT-2 Inhibitors in Patients with Type 2 Diabetes Mellitus and Abdominal Obesity: An Asian Perspective and Expert RecommendationsWayne Huey Herng Sheu, Siew Pheng Chan, Bien J Matawaran, et al.
Diabetes & Metabolism Journal|April 23, 2024
Efficacy and Safety of Alogliptin-Pioglitazone Combination for Type 2 Diabetes Mellitus Poorly Controlled with Metformin: A Multicenter, Double-Blind Randomized TrialJi-Yeon Park, Joonyub Lee, Yoon-Hee Choi, et al.
Diabetes, Obesity & Metabolism|July 3, 2019
Use of sodium-glucose co-transporter-2 inhibitors in patients with type 2 diabetes mellitus and multiple cardiovascular risk factors: An Asian perspective and expert recommendationsChaicharn Deerochanawong, Siew P Chan, Bien J Matawaran, et al.
Pageof 29